Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA will not meet action date for Ravicti NDA

Jan. 17, 2013

Metabolys divulges novel glucose-lowering agents

Jan. 17, 2013

New antidiabetic agents described in Metabolic Solutions Development patent

Jan. 16, 2013

Isis Pharmaceuticals patents antisense modulators of FGFR-4

Jan. 16, 2013

The Wisconsin Alumni Research Foundation patents novel vitamin D analogues

Jan. 16, 2013

Novel transgenic pig model of familial hypercholesterolemia

Jan. 16, 2013

Sanofi launches Amaryl OD 0.5 mg in Japan

Jan. 15, 2013

GlaxoSmithKline submits albiglutide BLA

Jan. 15, 2013

New endothelial lipase inhibitors synthesized at Shionogi & Co.

Jan. 15, 2013

Regeneron Pharmaceuticals patents novel antibodies to hANGPTL3

Jan. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...